These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11720478)

  • 1. No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.
    Jefferies S; Edwards SM; Hamoudi RA; A'Hern R; Foulkes W; Goldgar D; Eeles R;
    Br J Cancer; 2001 Nov; 85(9):1383-6. PubMed ID: 11720478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK; Zanation AM; Moss JR; Yarbrough WG
    Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
    Motsch C; Giers A; Boltze C; Evert M; Freigang B; Roessner A; Schneider-Stock R
    Laryngorhinootologie; 2004 Jan; 83(1):55-60. PubMed ID: 14740307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.
    Park HW; Song SY; Lee TJ; Jeong D; Lee TY
    Oncol Rep; 2007 Jul; 18(1):267-72. PubMed ID: 17549378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A gene inactivation in epithelial sporadic ovarian cancer.
    Niederacher D; Yan HY; An HX; Bender HG; Beckmann MW
    Br J Cancer; 1999 Aug; 80(12):1920-6. PubMed ID: 10471040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
    Yarbrough WG
    Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16(INK4alpha)/exon 2 mutations in squamous cell carcinoma of the head and neck region.
    Lehnerdt G; Fischer M
    Acta Otolaryngol; 2006 Apr; 126(4):414-7. PubMed ID: 16608795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?
    Geurts TW; Nederlof PM; van den Brekel MW; van't Veer LJ; de Jong D; Hart AA; van Zandwijk N; Klomp H; Balm AJ; van Velthuysen ML
    Clin Cancer Res; 2005 Sep; 11(18):6608-14. PubMed ID: 16166439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Ali MA; Beder L; Tamamura R; Katase N; Tominaga S; Yamanaka N; Shimizu K; Nagatsuka H
    Cancer Invest; 2009 Jul; 27(6):661-8. PubMed ID: 19488910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
    Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
    Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.
    Raschke S; Balz V; Efferth T; Schulz WA; Florl AR
    Genes Chromosomes Cancer; 2005 Jan; 42(1):58-67. PubMed ID: 15495191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study.
    Dessy E; Rossi E; Berenzi A; Tironi A; Benetti A; Grigolato P
    Histopathology; 2008 Mar; 52(4):475-82. PubMed ID: 18315600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region.
    Kujawski M; Jarmuz M; Rydzanicz M; Szukala K; Wierzbicka M; Grenman R; Golusinski W; Szyfter K
    Cancer Lett; 2004 May; 208(1):95-101. PubMed ID: 15105051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.